A blog chronicling the evolution and implementation of marijuana laws in the United States
Upcoming PLUS Webinar: “SPAC and Related IPO Litigation as it has Evolved & The Current State of SEC Regulation of Disclosure”
Thursday, September 23, 2021
Join leading securities partners Greg Markel and Gina Ferrari for a complimentary webinar put on by the Professional Liability Underwriting Society (PLUS) next week. The program “SPAC and Related IPO Litigation as it has Evolved
TBT readers are invited to join Seyfarth Shaw LLP’s upcoming webinar, “Risky Business: US Immigration Law and the Marijuana Industry,” on October 22 at 12 pm CT.
Register here
There is no cost to attend, but registration is required.
About the Program:
Despite the growing trend by states and foreign countries to legalize cannabis for recreational or medicinal use, and…
Continue Reading Upcoming Webinar: Risky Business: US Immigration Law and the Marijuana Industry
As more states legalize medicinal and recreational marijuana use, the conversation about how to manage Driving Under the Influence (DUI) laws has become increasingly prevalent– in legal, law enforcement, prosecution, and government circles, amongst others.…
Continue Reading Take it to the Limit
Cannabidiol (CBD) competed with Vitamin C as a top ingredient in new cosmetic products this past year, with promises of having anti-inflammatory effects and other healing properties. Amid the hype, at the end of 2018, the Agriculture Improvement Act of 2018, P.L. 115-334 (the “2018 Farm Bill”) was signed into law, changing the marketing of hemp and derivatives of cannabis and further removing hemp from the Controlled Substances Act thereby making it no longer an illegal substance under federal law. See Section 297A. The 2018 Farm Bill amended the definition of “hemp” to specifically include “all derivatives, extracts, cannabinoids,” which has been construed as an attempt to include hemp-based CBD under the definition of industrial hemp. The 2018 Farm Bill allows, subject to certain restrictions, hemp cultivation, along with the sale, transport (including via interstate commerce), and possession of hemp-derived products.…
Continue Reading “C” is for…
Cannabis and CBD-driven business format franchising is coming.
Franchising in the United States has deep historical roots in a nearly endless array of industries, from Benjamin Franklin’s Franchise-esque Printing Business to the Singer Sewing Machine’s profit-share model (1851) to Martha Matilda Harper’s Creation of the Modern Franchise with the Harper Method – all sixty-plus years before Ray Kroc created the…
Continue Reading High Risk, High Reward: When is it Time to Establish or Grow a Cannabis Franchise System?
The 2018 Farm Bill lifted the ban on hemp, creating a lot of buzz about products derived from hemp, including hemp-derived CBD oil.
Although this creates an exciting market opportunity for veterinarians and members of the pet industry, some important issues still need to be resolved.
Passing the Farm Bill did not legalize “pot for pets” — but it does mean pets can enjoy the benefits of CBD derived from industrial hemp.…
Continue Reading Pets and Pot: Cannabis and Pet Products
This is Washington, and we do like to speak in initials. A plain English translation of the title of this piece would read “FDA ‘places FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols in Schedule V.’” DEA Final Order, Docket No. DEA-486 Schedule V drugs include cough medicine with codeine and many pain relievers that still require a prescription. So, really what this order does is allow doctors in the US legally to prescribe the recently approved epilepsy drug, Epidiolex, and allows pharmacies, rather than marijuana dispensaries, legally to sell the drug.…
Continue Reading FDA: .1% CBD OK
It’s only the second week of January, and it has already been a wild year in the cannabis industry. First, legal sales of recreational marijuana started in California, and then Jeff Sessions rescinded the Cole Memorandum. What next? Here are seven stories to follow in 2018.…
Continue Reading And Now for the Rest of the Year
As of January 2017, 29 states have legalized medical marijuana. However, marijuana remains a Schedule l substance under the Controlled Substances Act. Substances in Schedule l are determined by the Food and Drug Administration (FDA) to have no medical use, and states that allow the use of marijuana for medical use violate federal law.…
Continue Reading Food and Drug Administration’s Regulation of Cannabis
Data privacy and the cannabis industry. The growing intersection of the two is yet another sign that cannabis has come a long way from the black market. As more states legalize cannabis for medical and recreational purposes, and the industry faces greater regulation and tracking, data privacy becomes increasingly important in the cannabis world.…
Continue Reading Data Privacy and Cannabis? You’ve Come a Long Way, Baby…
